2023-05-05

Good news! Anling Biomed (Shenzhen) Co. Ltd. has successfully passed the GLP certification issued by the National Medical Products Administration.

Good news! Anling (Shenzhen) has successfully passed the GLP certification issued by NMPA Recently, Anling Biomed(Shenzhen) Co., Ltd., a wholly-owned subsidiary of ZSHK LaboratoriesLimited（ZSHK）, received a GLP certificate (registration ...

Read more +

2023-04-24

ZSHK successfully hosted a reception banquet.

On the evening of February 28th, 2023, on the banks of the fragrant harbor, with a gentle breeze blowing, to welcome and celebrate the visit of the China Pharmaceutical Innovation and Research Development Association (PhIRDA) delegation to H...

Read more +

2023-02-16

Great News|Anling Biomed (Suzhou) Successfully Gains Extending GLP Accreditation from NMPA

Recently, Anling Biomed (Suzhou)Co., Ltd (Anling (Suzhou))wholly-owned subsidiaries of ZSHK Laboratories Limited (ZSHK) has been awarded GLP accreditation (Registration Number:GLP23002157) issued by the National Medical Products Administrati...

Read more +

2022-11-28

Preclinical CRO Company ZSHK Announces Completion of Nearly ￥100 Million Series B Financing
Such Series of Financing was Led by AZ-CICC Healthcare Fund

On 28th November 2022 , ZSHK Laboratories Limited (ZSHK) announces its completion of nearly ￥100 million series B financing. Such series of financing was led by AZ-CICC Healthcare Fund and followed by existing shareholdersAscendum Capital....

Read more +

2022-11-11

ZSHK was Invited to the Second Asia Summit on Global Health

On 10 th November 2022. Hong Kong China. The second Asia Summit on Global Health (ASGH) was staged grandly at theHong Kong Convention and Exhibition Centre by the Hong Kong Government and Hong Kong Trade Development Council. The summit was t...

Read more +